- Home
- CGBD vs PSNL Comparison
CGBD vs PSNL Comparison
Compare CGBD & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CGBD | PSNL |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | United States |
| Employees | 2500 | N/A |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 759.8M | 729.1M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CGBD | PSNL |
|---|---|---|
| Price | $11.03 | $6.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $12.92 | $12.20 |
| AVG Volume (30 Days) | 759.2K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 15.05% | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,648,000.00 |
| Revenue This Year | $3.74 | $15.47 |
| Revenue Next Year | $1.80 | $39.24 |
| P/E Ratio | $10.36 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.64 | $2.86 |
| 52 Week High | $15.15 | $11.50 |
Technical Indicators
Market Signals| Indicator | CGBD | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 46.28 | 39.36 |
| Support Level | $10.64 | $6.59 |
| Resistance Level | $11.44 | $6.94 |
| Average True Range (ATR) | 0.32 | 0.49 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 47.38 | 25.57 |
Price Performance
Historical ComparisonAbout CGBD Carlyle Secured Lending Inc.
Carlyle Secured Lending Inc is a specialty finance company that is a closed-end, externally managed, non-diversified management investment company. It focuses on providing directly originated, financing solutions across the capital structure, with a focus on senior secured lending to middle-market companies located in the United States. The company's investment objective is to generate current income and capital appreciation through debt investments in U.S. middle-market companies.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.